ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+56.19%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$178M
AUM Growth
+$40.1M
Cap. Flow
+$6.94M
Cap. Flow %
3.91%
Top 10 Hldgs %
56.23%
Holding
55
New
11
Increased
14
Reduced
9
Closed
15

Top Buys

1
TRML icon
Tourmaline Bio
TRML
$6.07M
2
OCUL icon
Ocular Therapeutix
OCUL
$5.84M
3
SRPT icon
Sarepta Therapeutics
SRPT
$5.31M
4
MRSN icon
Mersana Therapeutics
MRSN
$5.26M
5
RVMD icon
Revolution Medicines
RVMD
$4.59M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$10.1M
2
VTYX icon
Ventyx Biosciences
VTYX
$7.13M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
$4.31M
4
ALKS icon
Alkermes
ALKS
$3.54M
5
REPL icon
Replimune Group
REPL
$2.57M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VSTM icon
26
Verastem
VSTM
$663M
$1.89M 1.06%
232,249
+2,249
+1% +$18.3K
APLT icon
27
Applied Therapeutics
APLT
$68.2M
$1.76M 0.99%
+525,100
New +$1.76M
ELVN icon
28
Enliven Therapeutics
ELVN
$1.19B
$1.71M 0.97%
123,876
+20,276
+20% +$281K
FDMT icon
29
4D Molecular Therapeutics
FDMT
$340M
$1.51M 0.85%
+74,500
New +$1.51M
LPTX icon
30
Leap Therapeutics
LPTX
$11.7M
$1.47M 0.83%
354,166
– –
CLRB icon
31
Cellectar Biosciences
CLRB
$15.9M
$1.32M 0.74%
15,917
+11,874
+294% +$987K
INSM icon
32
Insmed
INSM
$30.7B
$914K 0.51%
+29,500
New +$914K
ARGX icon
33
argenx
ARGX
$45.9B
$913K 0.51%
+2,400
New +$913K
VRNA
34
Verona Pharma
VRNA
$9.2B
$378K 0.21%
+19,000
New +$378K
SWTX
35
DELISTED
SpringWorks Therapeutics
SWTX
$365K 0.21%
+10,000
New +$365K
CNTA
36
Centessa Pharmaceuticals
CNTA
$2.11B
$304K 0.17%
38,138
-285,211
-88% -$2.27M
TYRA icon
37
Tyra Biosciences
TYRA
$674M
$123K 0.07%
+8,867
New +$123K
NUVB.WS icon
38
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$5.45K ﹤0.01%
90,832
– –
ACRS icon
39
Aclaris Therapeutics
ACRS
$227M
– –
-121,692
Closed -$834K
ALKS icon
40
Alkermes
ALKS
$4.94B
– –
-126,500
Closed -$3.54M
AVXL icon
41
Anavex Life Sciences
AVXL
$807M
– –
0
– –
BCLI
42
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
0
– –
BMEA icon
43
Biomea Fusion
BMEA
$114M
– –
-39,935
Closed -$550K
ETNB icon
44
89bio
ETNB
$1.32B
– –
-32,800
Closed -$506K
CBIO
45
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
– –
-275
Closed -$41.3K
GPCR icon
46
Structure Therapeutics
GPCR
$1.27B
– –
-5,000
Closed -$252K
IMA
47
ImageneBio, Inc. Common Stock
IMA
$89M
– –
-45,918
Closed -$2.39M
IONS icon
48
Ionis Pharmaceuticals
IONS
$9.76B
– –
-11,300
Closed -$513K
KRON
49
DELISTED
Kronos Bio
KRON
– –
-718,739
Closed -$934K
OLMA icon
50
Olema Pharmaceuticals
OLMA
$570M
– –
-153,007
Closed -$1.89M
1
2
3